<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1.Name and Address of Reporting Person*
Formela, Jean-Francois
222 Berkeley Street, Suite 1950
Boston, Massachusetts 02116
2. Date of Event Requiring Statement (Month/Day/Year)
06/26/00
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary)
4. Issuer Name and Ticker or Trading Symbol
deCODE genetics, Inc. ("DCGN")
5. Relationship of Reporting Person(s) to Issuer (Check all
applicable) (X) Director ( ) 10% Owner ( ) Officer (give
title below) ( ) Other (specify below)
6. If Amendment, Date, of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
-----------------------------------------------------------------------------------
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security 2. Amount of Securities 3. Ownership Form: Direct 4. Nature of Indirect
(Instr. 4) Beneficially Owned (D) or Indirect (I) Beneficial Ownership
(Instr. 4) (Instr. 5) (Instr. 5)
<S> <C> <C> <C>
------------------------------------------------------------------------------------
Series A Preferred 1,042,541 I(1) Atlas Venture
Fund II, L.P.
-------------------------------------------------------------------------------------------------------
Series A Preferred 1,042,541 I(1) Atlas Venture
Europe Fund B.V.
-------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------
=======================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities
beneficially owned directly or indirectly.
* If the for is filed by more than one reporting person, see 5(b)(v).
<PAGE>
FORM 3 (continued)
<TABLE>
<CAPTION>
Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible
securities)
========================================================================================
1. Title of Deri- 2. Date Exer- 3. Title and 4. Conver- 5. Owner- 6. Nature of Indirect
vate Security cisable and Amount of sion or Ship Beneficial Ownership
(Instr. 4) Expiration Underlying Exercise Form of (Instr. 5)
Date Derivative Price of Deriv-
(Month/Day/Year) Security Deri- ative
(Instr. 4) vative Security:
Security Direct
Title Amount (D) or
Date Expira- or Indirect
Exer- tion Number (I)
cisable Date of (Instr. 5)
Shares
<S> <C> <C> <C> <C> <C> <C> <C>
-----------------------------------------------------------------------------------------------------------
Warrant 10/30/97 8/26/05 Series 125,000 $1.00 I(1) Atlas Venture Fund
A Pref. II, L.P.
--------------------------------------------------------------------------------------------
Warrant 10/30/97 8/26/05 Series 125,000 $1.00 I(1) Atlas Venture
A Pref. Europe Fund B.V.
------------------------------------------------------------------------------------------------------------
======================================================================================
</TABLE>
Explanation of Responses:
/s/ Jean-Francois Formela 6/23/00
------------------------------------- -------------------------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
